H. Michael Shepard
2011
In 2011, H. Michael Shepard earned a total compensation of $690.2K as Vice President and Chief Scientific Officer at Halozyme Therapeutics, a 31% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,000 |
|---|---|
| Option Awards | $170,788 |
| Salary | $300,000 |
| Stock Awards | $120,060 |
| Other | $9,330 |
| Total | $690,178 |
Shepard received $300K in salary, accounting for 43% of the total pay in 2011.
Shepard also received $90K in non-equity incentive plan, $170.8K in option awards, $120.1K in stock awards and $9.3K in other compensation.
Rankings
In 2011, H. Michael Shepard's compensation ranked 6,975th out of 10,747 executives tracked by ExecPay. In other words, Shepard earned more than 35.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,975 out of 10,747 | 35th |
Division Manufacturing | 2,541 out of 3,960 | 36th |
Major group Chemicals And Allied Products | 608 out of 1,038 | 41st |
Industry group Drugs | 412 out of 786 | 48th |
Industry Biological Products, Except Diagnostic Substances | 67 out of 162 | 59th |
Source: SEC filing on April 7, 2014.
Shepard's colleagues
We found six more compensation records of executives who worked with H. Michael Shepard at Halozyme Therapeutics in 2011.
2011
James Shaffer
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2011
David Ramsay
Halozyme Therapeutics